The children's vaccine initiative : achieving the vision

著者

書誌事項

The children's vaccine initiative : achieving the vision

Violaine S. Mitchell, Nalini M. Philipose, and Jay P. Sanford, editors ; Committee on the Children's Vaccine Initiative : Planning Alternative Strategies Toward Full U.S. Participation, Division of International Health, Institute of Medicine

National Academy Press, 1993

大学図書館所蔵 件 / 全2件

この図書・雑誌をさがす

注記

Support provided by the Agency for International Development, the Dept. of Health and Human Services, the Pharmaceutical Manufacturers Association, the United Nations Development Program, and the World Health Organization, Children's Vaccine Initiative

Includes bibliographical references

内容説明・目次

内容説明

The Children's Vaccine Initiative is an international endeavor to ensure that children throughout the world are immunized. This book notes that one of the best opportunities to address the growing problem of immunization in the United States and to improve the health of children in developing countries lies in marshaling the vaccine development and production efforts in the United States and abroad. The book contains information on the nature and status of vaccine development and production efforts in the United States and abroad, and it recommends ways to enhance participation in the International Children's Vaccine Initiative. Table of Contents FRONT MATTER 1 Executive Summary 2 Why a Children's Vaccine Initiative 3 Resources and Infrastructure 4 Vaccine Demand and Supply 5 Investing in New and Improved Vaccines 6 Stages of Vaccine Development 7 A Strategy to Enhance U.S. Participation in the Children's Vaccine Initiative Appendix A: Relevant Intellectual Property Rights Law Appendix B: National Vaccine Injury Compensation Program Appendix C: Regulatory Aspects of Vaccine Development, Manufacture, and Distribution Appendix D: Strategies for Achieving Full U.S. Participation in the Children's Vaccine Initiative Appendix E: Public Health Service Act (1944) Appendix F: National Vaccine Program Legislation Appendix G: Immunization Schedules Appendix H: Historical Record of Vaccine Product License Holders in the United States Appendix I: Working Group Participants Appendix J: Committee and Staff Biographies Appendix K: Acronyms

目次

  • 1 FRONT MATTER
  • 2 1 Executive Summary
  • 3 2 Why a Children's Vaccine Initiative
  • 4 3 Resources and Infrastructure
  • 5 4 Vaccine Demand and Supply
  • 6 5 Investing in New and Improved Vaccines
  • 7 6 Stages of Vaccine Development
  • 8 7 A Strategy to Enhance U.S. Participation in the Children's Vaccine Initiative
  • 9 Appendix A: Relevant Intellectual Property Rights Law
  • 10 Appendix B: National Vaccine Injury Compensation Program
  • 11 Appendix C: Regulatory Aspects of Vaccine Development, Manufacture, and Distribution
  • 12 Appendix D: Strategies for Achieving Full U.S. Participation in the Children's Vaccine Initiative
  • 13 Appendix E: Public Health Service Act (1944)
  • 14 Appendix F: National Vaccine Program Legislation
  • 15 Appendix G: Immunization Schedules
  • 16 Appendix H: Historical Record of Vaccine Product License Holders in the United States
  • 17 Appendix I: Working Group Participants
  • 18 Appendix J: Committee and Staff Biographies
  • 19 Appendix K: Acronyms

「Nielsen BookData」 より

詳細情報

ページトップへ